KIA
WST icon

Knollwood Investment Advisory’s West Pharmaceutical WST Stock Holding History

Knollwood Investment Advisory’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$302K Hold
840
– – 0.03% 235
2026
Q1 		$211K Hold
840
– – 0.02% 295
2025
Q4 		$231K Hold
840
– – 0.02% 306
2025
Q3 		$220K Buy
+840
New +$204K 0.02% 339
2025
Q1 		– Sell
-6,700
Closed -$2.19M – 361
2024
Q4 		$2.19M Hold
6,700
– – 0.23% 111
2024
Q3 		$2.01M Hold
6,700
– – 0.22% 116
2024
Q2 		$2.21M Buy
6,700
+5,860
+698% +$2.07M 0.25% 100
2024
Q1 		$332K Hold
840
– – 0.06% 174
2023
Q4 		$296K Buy
+840
New +$297K 0.06% 175

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Knollwood Investment Advisory's WST Position: Q2 2026 in Review

Knollwood Investment Advisory held its West Pharmaceutical (WST) position steady in Q2 2026 at 840 shares worth $302K. The position accounts for 0.03% of the portfolio, ranked #235.

Knollwood Investment Advisory first reported a position in WST in Q4 2023 and has held it in 9 quarters since. The position peaked at $2.21M in Q2 2024. 833 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Knollwood Investment Advisory held 840 shares of West Pharmaceutical worth $302K as of Q2 2026.
  • Knollwood Investment Advisory left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up 0.03% of Knollwood Investment Advisory's portfolio in Q2 2026, its #235 holding.
  • Knollwood Investment Advisory first reported a position in West Pharmaceutical in Q4 2023 and has held it in 9 quarters since.
  • Knollwood Investment Advisory's West Pharmaceutical position peaked at $2.21M in Q2 2024.
  • 833 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Knollwood Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.